Roles
- Professor of Radiation Oncology
-
Biography
Dr. Yechieli is an Associate Professor in Radiation Oncology at the University of Miami and Medical Director for the department of Radiation Oncology at Jackson Memorial Hospital. He specializes in treating patients with sarcoma, lung cancers, brain metastases, genitourinary tumors and keloids. He has experience and expertise in the use of multiple treatment techniques including Proton therapy, Stereotactic Radiation, Gamma-Knife Radiosurgery and MR-Guided radiation therapy. His research interests are in delivery and outcomes for cancer patients, with a focus on patient-centered care, and education of the next-generation of radiation oncologists. He received his undergraduate degree from Ner Israel Rabbinical College in Baltimore graduated medical school from University of Maryland, Baltimore. He completed his residency in Radiation Oncology at Henry Ford Hospital in Detroit MI, where he served as Chief Resident from 2013-14.
Dr. Yechieli is the co-leader of the thoracic site disease group at Sylvester Comprehensive Cancer Center and serves on multiple local and national leadership committees and organizations. He is an avid runner, ice-hockey player, and when the ice melts, can be found swimming too. -
Education & Training
Education
Post Graduate Training
Licensures and Certifications
-
Honors & Awards
-
Research Interests
Outcomes based research, health disparities research, and treatment and outcomes for adolescent and young adults facing cancer. -
Publications
Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.Professional Activities
Clinical Trials
Viewing 0 of 5 clinical trials.
-
MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
- Principal Investigator: Raphael Yechieli
- Study Phase: Phase 3
- Enrollment Status: Not Accepting
-
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
- Principal Investigator: Raphael Yechieli
- Study Phase: Phase 2/Phase 3
- Enrollment Status: Not Accepting
-
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
- Principal Investigator: Raphael Yechieli
- Study Phase: Phase 2
- Enrollment Status: Not Accepting
-
The purpose of this study is to assess the injection of the radiation enhancer JNJ-90301900 into your cancer prior to concurrent chemoradiotherapy (cCRT) followed by immunotherapy (cIT) compared with cCRT alone followed by cIT to help researchers understand more about the possible effectiveness and safety of JNJ-90301900 in patients with locally advanced and unresectable Stage III Non-Small Cell Lung Cancer (NSCLC).
- Principal Investigator: Raphael Yechieli
- Study Phase: Phase II
- Enrollment Status: Open
-
The purpose of this study is to compare the usual treatment alone to using SBRT plus the usual treatment. The addition of SBRT to the usual treatment could stop your cancer from growing. But, it could also cause side effects, which are described in the risks section below.
- Principal Investigator: Raphael Yechieli
- Study Phase: Phase II/III
- Enrollment Status: Not Accepting
